MultiPlan Corporation (MPLN)
USD 23.15
(-1.53%)
USD 23.15
(-1.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.48 Billion USD | 0.86% |
| 2022 | 4.44 Billion USD | -6.17% |
| 2021 | 4.74 Billion USD | 5.68% |
| 2020 | 4.48 Billion USD | -17.05% |
| 2019 | 5.4 Billion USD | -3.4% |
| 2018 | 5.59 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 4.48 Billion USD | 0.19% |
| 2024 Q3 | 4.45 Billion USD | -0.74% |
| 2024 Q1 | 4.47 Billion USD | -0.23% |
| 2023 Q2 | 4.55 Billion USD | 3.99% |
| 2023 FY | 4.48 Billion USD | 0.86% |
| 2023 Q4 | 4.48 Billion USD | -0.16% |
| 2023 Q3 | 4.49 Billion USD | -1.29% |
| 2023 Q1 | 4.37 Billion USD | -1.59% |
| 2022 Q2 | 4.56 Billion USD | -0.17% |
| 2022 Q1 | 4.57 Billion USD | -3.56% |
| 2022 FY | 4.44 Billion USD | -6.17% |
| 2022 Q4 | 4.44 Billion USD | -0.67% |
| 2022 Q3 | 4.47 Billion USD | -1.88% |
| 2021 Q1 | 4.77 Billion USD | 6.52% |
| 2021 Q4 | 4.74 Billion USD | 0.91% |
| 2021 FY | 4.74 Billion USD | 5.68% |
| 2021 Q3 | 4.69 Billion USD | -1.43% |
| 2021 Q2 | 4.76 Billion USD | -0.26% |
| 2020 Q2 | 5.24 Billion USD | 23936.26% |
| 2020 Q4 | 4.48 Billion USD | -14.4% |
| 2020 FY | 4.48 Billion USD | -17.05% |
| 2020 Q3 | 5.24 Billion USD | -0.1% |
| 2020 Q1 | 21.82 Million USD | -99.6% |
| 2019 Q1 | 5.01 Million USD | 0.0% |
| 2019 FY | 5.4 Billion USD | -3.4% |
| 2019 Q4 | 5.39 Billion USD | 0.0% |
| 2018 FY | 5.59 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Well Corporation | -360.25 Million USD | 1345.352% |
| Doximity, Inc. | -82.23 Million USD | 5555.325% |
| Evolent Health, Inc. | 451.97 Million USD | -892.631% |
| Phreesia, Inc. | -75.53 Million USD | 6039.348% |
| Teladoc Health, Inc. | 468.6 Million USD | -857.402% |
| Veeva Systems Inc. | -647.71 Million USD | 792.654% |